1. Home
  2. GDRX vs MLTX Comparison

GDRX vs MLTX Comparison

Compare GDRX & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

HOLD

Current Price

$2.52

Market Cap

868.9M

Sector

Technology

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$15.91

Market Cap

979.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDRX
MLTX
Founded
2011
2021
Country
United States
Switzerland
Employees
738
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
868.9M
979.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GDRX
MLTX
Price
$2.52
$15.91
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$4.78
$22.22
AVG Volume (30 Days)
2.1M
3.6M
Earning Date
02-26-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$800,651,000.00
N/A
Revenue This Year
$2.30
N/A
Revenue Next Year
$2.63
N/A
P/E Ratio
$29.60
N/A
Revenue Growth
1.30
N/A
52 Week Low
$2.47
$5.95
52 Week High
$5.81
$62.75

Technical Indicators

Market Signals
Indicator
GDRX
MLTX
Relative Strength Index (RSI) 31.70 54.17
Support Level $2.47 $15.70
Resistance Level $2.63 $16.86
Average True Range (ATR) 0.11 1.30
MACD -0.02 0.03
Stochastic Oscillator 11.23 62.40

Price Performance

Historical Comparison
GDRX
MLTX

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: